Caladrius Biosciences Inc. (0HS8:LSE) Annual Income Statement ()
0HS8:LSE Quarterly Financials ()
Frequently Asked Questions About Caladrius Biosciences Inc. (0HS8:LSE) Stock
Caladrius Biosciences Inc.'s (0HS8:LSE) last reported annual revenue was N/A.
Caladrius Biosciences Inc.'s (0HS8:LSE) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Caladrius Biosciences Inc.'s(0HS8:LSE) is not profitable as of its last reported annual financials.
The net profit margin for Caladrius Biosciences Inc.'s(0HS8:LSE) from its laster reported year is N/A
The return on equity (ROE) for Caladrius Biosciences Inc.'s(0HS8:LSE) from its last reported annual financials is : -44.03%
The return on assets (ROA) for Caladrius Biosciences Inc.'s(0HS8:LSE) from its last reported annual financials is : -28.72%
The return on invested capital (ROIC) for Caladrius Biosciences Inc.'s(0HS8:LSE) from its last reported annual financials is : 9.28%
The Debt to Equity ratio for Caladrius Biosciences Inc.'s(0HS8:LSE) from its last reported annual financials is : 0.00%
The dividend yield for Caladrius Biosciences Inc.'s(0HS8:LSE) from its laster reported year is 0.00%
Caladrius Biosciences Inc.'s(0HS8:LSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0HS8:LSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
